Navigation Links
Reportlinker Adds Product Profiles: Multiple Sclerosis - Gilenya Raises Bar for New Market Entrants
Date:6/27/2011

rologists prescribe Gilenya because of its strong efficacy in treatment resistant patients as well as its convenient oral mode of administration. However, long term cancer and infection risk remain the main concerns.

The multiple sclerosis market has been lucrative for drug companies over the last decade with limited competition and periodic price increases. However, as this dynamic is changing with increased competition, existing players are expanding their portfolios with new and improved therapies.

Monoclonal antibodies have demonstrated potent efficacy in Phase II trials, surpassing all existing therapies. However, excitement is tempered with safety concerns that include risk of malignancy and severe infections. Still, as seen with Tysabri, impressive efficacy may outweigh the risks for more severe multiple sclerosis patients.

Your key questions answered

* How well do agents in late-stage development for multiple sclerosis compare to one another and the current standard of care?

* What is the most promising treatment in development for multiple sclerosis?

* How do US neurologists perceive Gilenya and key pipeline agents as new treatments of multiple sclerosis?

Executive Summary

Strategic scoping and focus

Datamonitor key findings

Related reports

OVERVIEW

Catalyst

Summary

MARKET OVERVIEW

Product overview

Datamonitor's assessment summary

MARKETED PRODUCT PROFILES

Gilenya (fingolimod; Novartis/Mitsubishi Tanabe Pharma)

Drug profile

Development overview

SWOT analysis

Satisfaction of unmet needs

Product positioning

Physician perception of Gilenya

Clinical and commercial attractiveness

Avonex (interferon beta-1a; Biogen Idec)

Drug profile

Development overview

SWOT analysis

Satisfaction of unmet needs

Product positioning

Clinical and commerci
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... MONROVIA, Calif. , April 21, 2015 ... developer, manufacturer and marketer of implantable lenses and delivery ... of Directors has appointed J. Steven Roush , ... total number of members on STAAR,s Board to seven.Mr. ... reporting agencies expertise, largely gained over a 39 year ...
(Date:4/21/2015)... and CAMBRIDGE, Mass. ... ( Tokyo : 4503) and Potenza ... of immuno-oncology programs, today announced an exclusive research ... is to advance a portfolio consisting of programs ... pathways, co-stimulatory signals and regulatory T cells. The ...
(Date:4/21/2015)... TOKYO , April 21, 2015 /PRNewswire/ ... conferences, has just announced Medtech Partnering Forum 2015 ... technology industry. The event, held May 28–29 in ... international medtech partnering conference in Japan ... new developments in the rapidly changing medical technology industry ...
Breaking Medicine Technology:J. Steven Roush, CPA Appointed to STAAR Surgical Board of Directors 2J. Steven Roush, CPA Appointed to STAAR Surgical Board of Directors 3Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics 2Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics 3Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 2Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 3Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 4
... Feb. 9, 2011 GeoVax Labs, Inc. (OTC Bulletin ... develops and tests innovative HIV/AIDS vaccines, announced today the ... Alabama Vaccine Research Clinic (AVRC) of the University of ... therapeutic vaccine trial. Although the GeoVax vaccines are currently ...
... The Covaris® LE220™ high performance ultra-sonicator has received ... at the LabAutomation 2011 conference in Palm Springs ... laboratory automation conference and exhibition, bringing science, technology, and ... LabAutomation are evaluated by a team of industry experts. ...
Cached Medicine Technology:GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine 2GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine 3Covaris Receives the Society for Laboratory Automation and Screening (SLAS) New Product Award at LabAutomation 2011 2
(Date:4/21/2015)... (PRWEB) April 21, 2015 Henry Mayo ... Summit Care Exchange to automatically send continuation ... it needed to further improve communication with clinics and ... Summit Provider Alert solution. , “Provider Alert ... retrieve the patient information they need to provide continuing ...
(Date:4/21/2015)... “ ZeroWire ” was featured on NewsWatch as ... look at the latest and coolest technology products and ... for NewsWatch and a technology expert, conducted the review ... system and lifestyle management hub. , According to the ... burglaries in 2010. It goes without saying that home ...
(Date:4/21/2015)... BC (PRWEB) April 21, 2015 Angelo’s ... complimentary pick-up and delivery for clients that avail the ... Surrey by Angelo’s is done with hi-tech equipments, making ... for customers. They use all natural, high pressure steam ... well as hand washing for area rugs made with ...
(Date:4/21/2015)... Lowcostcarinsuranceprice.com has released a new blog post ... for SUVs. , SUVs are large vehicles that fare ... SUV and a smaller regular car shows that passengers from ... makes SUV safer in crashes, but these large vehicles may ... , It is now possible to find low cost ...
(Date:4/21/2015)... On April 8th, 2015, Choices Recovery ... the world famous Avalon Hollywood. Organized by Debbie Durkin, ... TV and film, the EcoLuxe Lounge is a premier ... ceremonies and festivals throughout the year. A gathering of ... socially conscious products and services, this daylong event is ...
Breaking Medicine News(10 mins):Health News:Henry Mayo Newhall Hospital to Improve Ambulatory Information Sharing with Summit Healthcare's Summit Provider Alert 2Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Angelo’s FabriClean Now Offers Area Rug Cleaning in South Surrey with Complimentary Pick-Up and Delivery 2Health News:Auto Insurance Quotes For SUVs Are Available Online 2Health News:Hollywood's Santana Dempsey and Choices Recovery South Bend Examine Victory over Personal Struggles 2
... As we approach the summer,when many of us are ... Interactive(R) for Florastor(R), the world,s,top-selling probiotic, found that the ... within the U.S., while just 15 percent say they ... don,t travel at,all., While a lot of thought ...
... Cleveland Clinic announced today that,the Cleveland Clinic Lerner ... providing all its students with full tuition scholarships,beginning ... fifth year in existence, the Cleveland Clinic Lerner,College ... physician scientists,who are capable of furthering medical research ...
... May 20, 2008- Maxi-K gene therapy may be a ... dysfunction (ED) is not treatable with oral therapy. Two ... of the American Urological Association (AUA) may give hope ... in a special press conference on May 20, 2008 ...
... 2008 Patients with metabolic syndrome disorders, including diabetes ... develop uric-acid stones than other type of calculi, ... Annual Scientific Meeting of the American Urological Association ... uric acid stones could benefit from additional health ...
... Association (NEDA) and the Academy for Eating Disorders ... a statewide initiative,in Washington to help families access ... Entitled the Worldwide Charter for Action on Eating ... families and their,treatment team to ensure the highest ...
... for $10 and Increases the ... a Discount, LOS ANGELES, May 14 Starting ... -- offering customers lower,prices and additional drug choices to ... for only $10 on its expanded generic drug,program. Ralphs ...
Cached Medicine News:Health News:Survey Reveals Most Americans Planning Vacations Within the U.S.; Tummy Troubles Top Travel Health Woes 2Health News:Survey Reveals Most Americans Planning Vacations Within the U.S.; Tummy Troubles Top Travel Health Woes 3Health News:Cleveland Clinic Lerner College of Medicine to Offer Full Tuition Scholarships for All Students 2Health News:Cleveland Clinic Lerner College of Medicine to Offer Full Tuition Scholarships for All Students 3Health News:AUA 2008: Maxi-K gene transfer may prove to be safe and effective erectile dysfunction treatment 2Health News:AUA 2008: Uric acid stones may indicate arteriosclerotic diseases 2Health News:Eating Disorder Experts, Advocates Introduce Patient Bill of Rights To Ensure Quality Care in Washington State and Throughout U.S. 2Health News:Ralphs Expands Discounted Generic Drug Program 2Health News:Ralphs Expands Discounted Generic Drug Program 3
... of Ang II is a ... pharmacological effect and efficiency of ... converting enzyme inhibitors (ACE Inhibitors) ... as well as for the ...
Anti-RSV IgM Assay (ELISA)....
One step Immunochromatographic Assay for the detection of Respiratory Syncytial Virus...
Immunofluorescence test for detecting RSV in direct specimens and cultures....
Medicine Products: